Doximity (NASDAQ:DOCS) Posts Quarterly Earnings Results

Doximity (NASDAQ:DOCS) released its earnings results on Thursday. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.07, Briefing.com reports. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the prior year, the company earned $0.30 EPS. The business’s revenue was up 23.2% on a year-over-year basis. Doximity updated its FY 2026 guidance to EPS and its Q3 2026 guidance to EPS.

Doximity Price Performance

NASDAQ:DOCS traded down $8.39 during mid-day trading on Friday, reaching $54.20. The stock had a trading volume of 5,709,533 shares, compared to its average volume of 2,085,829. The stock has a market cap of $10.15 billion, a P/E ratio of 54.20, a PEG ratio of 4.10 and a beta of 1.36. The business’s 50 day moving average is $69.27 and its 200 day moving average is $62.61. Doximity has a fifty-two week low of $47.66 and a fifty-two week high of $85.21.

Insiders Place Their Bets

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $66.44, for a total value of $132,880.00. Following the completion of the sale, the director owned 19,839 shares of the company’s stock, valued at $1,318,103.16. The trade was a 9.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the sale, the director owned 3,221 shares of the company’s stock, valued at approximately $241,575. This trade represents a 86.13% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 32,000 shares of company stock valued at $2,339,580 over the last quarter. Insiders own 31.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Doximity by 0.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock valued at $2,262,000 after acquiring an additional 210 shares during the period. California State Teachers Retirement System lifted its position in shares of Doximity by 0.5% during the 2nd quarter. California State Teachers Retirement System now owns 105,666 shares of the company’s stock worth $6,482,000 after purchasing an additional 486 shares during the last quarter. Quantinno Capital Management LP lifted its holdings in shares of Doximity by 6.8% during the second quarter. Quantinno Capital Management LP now owns 8,531 shares of the company’s stock worth $523,000 after buying an additional 545 shares during the last quarter. Vident Advisory LLC lifted its holdings in shares of Doximity by 15.0% during the second quarter. Vident Advisory LLC now owns 35,571 shares of the company’s stock worth $2,182,000 after buying an additional 4,639 shares during the last quarter. Finally, Focus Partners Wealth bought a new stake in shares of Doximity in the first quarter valued at approximately $283,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

DOCS has been the subject of a number of recent analyst reports. Truist Financial raised their price objective on shares of Doximity from $52.00 to $61.00 and gave the stock a “hold” rating in a research note on Thursday, July 17th. Zacks Research lowered Doximity from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Raymond James Financial set a $75.00 price target on Doximity in a report on Wednesday, September 10th. Canaccord Genuity Group upped their price target on Doximity from $59.00 to $67.00 and gave the company a “hold” rating in a research report on Thursday, September 18th. Finally, Robert W. Baird increased their price objective on Doximity from $75.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, September 11th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $69.84.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.